Spartan Bio Aims to Bring POC DNA Testing to Uncharted Waters | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – With the recent launch of what it says is the first point-of-care DNA test, Spartan Bioscience is hoping to bring its technology to areas not presently served by molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.